We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

122 hedge funds and large institutions have $992M invested in NxStage Medical Inc. in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 38 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

359% more call options, than puts

Call options by funds: $3.98M | Put options by funds: $868K

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

29% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 38

3% more funds holding

Funds holding: 118122 (+4)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

1% less capital invested

Capital invested by funds: $1B → $992M (-$8.92M)

Holders
122
Holders Change
+4
Holders Change %
+3.39%
% of All Funds
3.25%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.19%
New
13
Increased
49
Reduced
38
Closed
9
Calls
$3.98M
Puts
$868K
Net Calls
+$3.12M
Net Calls Change
+$3.11M
Name Holding Trade Value Shares
Change
Change in
Stake
Jennison Associates
26
Jennison Associates
New York
$9.98M +$10.2M +576,672 New
CM
27
Castleark Management
Illinois
$9.96M +$208K +11,800 +2%
EAM
28
EverPoint Asset Management
Connecticut
$8.65M +$7.22M +408,600 +447%
FLAM
29
First Light Asset Management
Minnesota
$7.12M +$681K +38,553 +10%
ACMM
30
Arbor Capital Management (Minnesota)
Minnesota
$6.78M +$6.92M +391,710 New
DCM
31
DAFNA Capital Management
California
$6.34M -$311K -17,600 -5%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$6.07M +$342K +19,362 +6%
N
33
Nuveen
North Carolina
$5.97M -$394K -22,305 -6%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$5.55M +$94K +5,320 +2%
WMSA
35
Weiss Multi-Strategy Advisers
New York
$4.78M -$415K -23,500 -8%
Millennium Management
36
Millennium Management
New York
$4.22M -$13.3M -754,511 -76%
Calamos Advisors
37
Calamos Advisors
Illinois
$3.98M
TCIM
38
TIAA CREF Investment Management
New York
$3.68M -$121K -6,856 -3%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$3.67M +$1.71M +96,851 +84%
ERSOT
40
Employees Retirement System of Texas
Texas
$3.42M
Charles Schwab
41
Charles Schwab
California
$3.18M +$143K +8,094 +5%
SC
42
Skylands Capital
Wisconsin
$3.05M +$98.9K +5,600 +3%
BIM
43
BlackRock Investment Management
Delaware
$2.94M +$61.6K +3,488 +2%
Two Sigma Investments
44
Two Sigma Investments
New York
$2.65M +$2.18M +123,629 +423%
WI
45
WHV Investments
California
$2.48M -$3.37M -190,965 -57%
CA
46
Continental Advisors
Utah
$2.39M
Norges Bank
47
Norges Bank
Norway
$2.23M -$438K -24,814 -16%
MAA
48
Managed Account Advisors
New Jersey
$2.13M -$754K -42,698 -26%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$2.02M
NFA
50
Nationwide Fund Advisors
Ohio
$2.01M +$1.22M +69,313 +149%

NXTM Hedge Fund Activity: Q1 2015 in Review

122 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2015, worth a combined $992M — down 0.89% from $1B a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new NXTM positions and 9 closed out — a net gain of 4 holders — while 49 added to existing stakes and 38 trimmed.

The largest buyer was Chartwell Investment Partners, adding an estimated $30.7M. The largest seller was Fidelity Investments, cutting an estimated $35.6M.

  • 122 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2015, up from 118 in Q4 2014.
  • Funds reported $992M of NxStage Medical Inc. stock for Q1 2015, down 0.89% quarter-over-quarter.
  • 13 funds opened new NxStage Medical Inc. positions in Q1 2015 and 9 closed out, a net change of +4 holders.
  • The largest NxStage Medical Inc. buyer in Q1 2015 was Chartwell Investment Partners, an estimated $30.7M added.
  • The largest NxStage Medical Inc. seller in Q1 2015 was Fidelity Investments, an estimated $35.6M sold.

Based on aggregated 13F filings for Q1 2015.